- Bay Area Times
- Posts
- Novo Nordisk moves to secure rapid FDA approval for 7.2mg Wegovy dose
Novo Nordisk moves to secure rapid FDA approval for 7.2mg Wegovy dose
Bay Area Times
November 28, 2025
Brought to you by:
Top stories today:
- Novo Nordisk moves to secure rapid approval for 7.2mg Wegovy dose
- OpenAI data-center partners said to near $100B debt, eye $38B more
- Project Prometheus, Jeff Bezos’ venture, acquires General Agents
- Upbit halts deposits, withdrawals after ~$30M unauthorized transfer
- Alibaba unveils Quark S1, G1 AI glasses with translucent displays
- Trump pushes “reverse migration” plan following D.C. attack
0. Data and calendar
All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).
No major events today.
Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):
1. Novo Nordisk moves to secure rapid FDA approval for 7.2mg Wegovy dose
The 1,407-person trial showed the 7.2mg dose delivering 20.7% weight loss over 72 weeks.
Under the FDA’s new Commissioner’s National Priority Voucher program, the application is being fast-tracked.
The 7.2mg formulation is already under review in the UK, EU, and other regions, with an EU decision expected in Q1 2026.
Late 2025: a U.S. decision is expected.
The Fintech Effect report just dropped, and it’s your inside look at what 2,000+ consumers expect from you in 2026.
This year’s report is packed with data-driven insights on onboarding, AI, lending, and trust, and how top fintechs can adapt fast to stay ahead:
Here’s what’s inside:
Where expectations are rising and where teams are falling short
The behaviors reshaping product strategy for 2026
What it takes to build trust, earn loyalty, and lead
Stay ahead of what’s next.
*Sponsored.
3. OpenAI data-center partners said to near $100B debt, eye $38B in new loans
SoftBank, Oracle, and CoreWeave have reportedly borrowed at least $30B to invest in OpenAI or to help set up its data centers.
Blue Owl Capital and infra firms including Crusoe rely on OpenAI-linked deals to support ~$28B in loans.
OpenAI plans to raise debt for these contracts, its execs said, but the financial load has so far fallen on partners and their lenders.
The commitments far exceed OpenAI’s expected ARR of ~$20B this year.
4. Project Prometheus, Jeff Bezos’ new venture, acquires agentic AI startup General Agents
General Agents co-founder Sherjil Ozair has updated his X bio to reflect the transition:
